Jason Throne's Insider Trades & SAST Disclosures
Jason Throne's most recent trade in Ideaya Biosciences Inc was a trade of 47,060 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jason Throne.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 47,060 | 1,360 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 27 Jun 2024 | 47,060 | 63,484 (0%) | 0% | 7.0 | 329,891 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 6,424 | 41,186 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.34 per share. | 27 Jun 2024 | 6,424 | 16,424 (0%) | 0% | 13.3 | 85,696 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 125,500 | 125,500 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 10,000 | 48,420 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 35.04 per share. | 15 Dec 2023 | 10,000 | 0 (0%) | 0% | 35.0 | 350,371 | Common Stock |
| Ideaya Biosciences Inc | Throne Jason | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.34 per share. | 15 Dec 2023 | 10,000 | 10,000 (0%) | 0% | 13.3 | 133,400 | Common Stock |
| Ideaya Biosciences Inc | Throne Jason | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 15 Dec 2023 | 10,000 | 10,000 (0%) | 0% | 7.0 | 70,100 | Common Stock |
| Ideaya Biosciences Inc | Throne Jason | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 10,000 | 47,610 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 10 Jul 2023 | 9,485 | 0 (0%) | 0% | 23.0 | 218,178 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.86 per share. | 10 Jul 2023 | 5,000 | 9,485 (0%) | 0% | 12.9 | 64,300 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 5,000 | 58,750 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 4,485 | 58,420 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 10 Jul 2023 | 4,485 | 4,485 (0%) | 0% | 7.0 | 31,440 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 31 May 2023 | 3,553 | 3,553 (0%) | 0% | 7.0 | 24,907 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 3,553 | 62,905 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 31 May 2023 | 3,553 | 0 (0%) | 0% | 23.0 | 81,792 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 31 May 2023 | 432 | 432 (0%) | 0% | 7.0 | 3,028 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 31 May 2023 | 432 | 0 (0%) | 0% | 23.0 | 9,938 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 432 | 66,458 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 500 | 66,890 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 22 May 2023 | 500 | 0 (0%) | 0% | 23 | 11,500 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 22 May 2023 | 500 | 500 (0%) | 0% | 7.0 | 3,505 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 63,750 | 63,750 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 25.17 per share. | 27 Jul 2021 | 10,000 | 0 (0%) | 0% | 25.2 | 251,683 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 10,000 | 62,610 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.34 per share. | 27 Jul 2021 | 10,000 | 10,000 (0%) | 0% | 13.3 | 133,400 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 06 Jul 2021 | 7,610 | 7,610 (0%) | 0% | 7.0 | 53,346 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 7,610 | 67,390 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 22.16 per share. | 06 Jul 2021 | 6,468 | 3,532 (0%) | 0% | 22.2 | 143,357 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 2,390 | 72,610 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.34 per share. | 06 Jul 2021 | 2,390 | 10,000 (0%) | 0% | 13.3 | 31,883 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 22.16 per share. | 06 Jul 2021 | 2,031 | 359 (0%) | 0% | 22.2 | 45,015 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 22.68 per share. | 06 Jul 2021 | 1,142 | 2,390 (0%) | 0% | 22.7 | 25,895 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 22.67 per share. | 06 Jul 2021 | 359 | 0 (0%) | 0% | 22.7 | 8,140 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 52,500 | 52,500 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 15.55 per share. | 04 Dec 2020 | 1,579 | 0 (0%) | 0% | 15.5 | 24,548 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 14.66 per share. | 04 Dec 2020 | 400 | 1,579 (0%) | 0% | 14.7 | 5,862 | Common Stock |
| Ideaya Biosciences Inc | Jason Throne | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Jason Throne | VP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 04 Jun 2020 | 2,205 | 0 (0%) | 0% | 8.7 | 19,087 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges